Intellego Technologies announces that Zhongyou Medical (Likang) will receive an exclusive market right to sell and market a certain type of Intellego`s UVC dosimeters and UVC devices in the healthcare sector in China. In exchange for the exclusive market right, Zhongyou Medical have committed to purchase products from Intellego to a minimum value of 16.2 million USD over a three-year period. Deliveries and payments will start immediately.

“We look forward to this collaboration and to expand our reach in the Asian healthcare market. We are impressed by Shanghai Zhongyou Medical High-Tech Co., Ltd market reach and we look forward to launch Intellego’s products in China for a start, with the potential for expansion from there”, says Claes Lindahl, CEO of Intellego Technologies.

“We look forward to capitalizing on this unique and huge market given the increasing demand to validate UVC disinfection results in the China healthcare market and we are impressed by Intellego`s technology and well- established global recognition.” Says Zhuang Zhong, President of Zhongyou Medical.

Zhongyou Medical (Likang) is a wholly owned subsidiary of Jiangsu Yuyue Medical Equipment and Supply Co., Ltd, which is listed on the Shenzhen Stock market, a leading distributor of a variety of disinfectant products into more than 3000 hospitals in China nationally.

Yuwell medical, with full name of Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. has established 12 R&D centers and 9 production bases in Shanghai, Shenzhen, Nanjing, Suzhou, Danyang, Tibet, the Netherlands, Germany, Italy, and other places, forming a complete global R&D, production, marketing, and service network that serves more than 300,000 medical institutions worldwide and covers 131 countries and regions, benefitting 300 million households around the world. https://www.yuwell.com/

Contacts

For further information, please contact:
Claes Lindahl, CEO Intellego Technologies AB
E-post: claes.lindahl@intellego-technologies.com
Telefon: +46 735 344 634

About Us

Intellego Technologies develops and manufactures color indicators that show the effect of irradiation with, among other things, invisible ultraviolet light, UV light. Color indicators are used globally in, for example, the disinfection industry, the sunscreen industry, and the manufacturing industry. Intellego's indicators have been developed from the company's patented photochromic ink, which can be adapted to different wavelengths of light and various application areas across a range of different industries. Intellego Technologies was founded in 2011, is headquartered in Stockholm, and is listed on the Nasdaq First North Growth Market.
The company's Certified Adviser on the Nasdaq First North Growth Market Stockholm is Carnegie Investment Bank AB (publ).

Intellego's website: https://intellego-technologies.com/en/

Subscribe to Intellego's press releases: https://intellego-technologies.com/sv/pressmeddelanden/

Contact the communications team: communications@intellego-technologies.com

This information is information that Intellego Technologies is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-06-26 15:00 CEST.

Attachments

Intellego China and Yuvio sign exclusive distribution agreement for the Chinese healthcare market to a value of 16.2 MUSD

© Modular Finance, source Nordic Press Releases